skip to main content

H.R. 2285: Heidi’s Law


The text of the bill below is as of Apr 10, 2019 (Introduced).


I

116th CONGRESS

1st Session

H. R. 2285

IN THE HOUSE OF REPRESENTATIVES

April 10, 2019

introduced the following bill; which was referred to the Committee on Oversight and Reform, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To require the Secretary of Health and Human Services to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and to require the Secretary of Transportation to issue regulations to include testing for methadone use in Department of Transportation drug tests.

1.

Short title

This Act may be cited as Heidi’s Law.

2.

Inclusion of testing for methadone use in certain drug testing procedures

(a)

Revision of mandatory guidelines

Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services shall revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, established pursuant to section 503(a) of Public Law 100–71 (5 U.S.C. 7301 note), to expand the opiate category on the list of substances authorized for testing to include methadone.

(b)

Publication of notice

Upon completion of the revision required under subsection (a), the Secretary shall publish a final notice in the Federal Register of such revision.

3.

Inclusion of methadone in Department of Transportation drug tests

Not later than 60 days after the final notice required under section 2(b) is published, the Secretary of Transportation shall issue such regulations as are necessary to update any regulations containing procedures for transportation employee workplace drug and alcohol testing programs to include testing for methadone use in drug-testing panels, consistent with the Mandatory Guidelines for Federal Workplace Drug Testing Programs as revised by the Secretary of Health and Human Services under section 2.

4.

To compel the Secretary to periodically update the mandatory guidelines for Federal workplace drug testing

(a)

In general

On an annual basis, the Secretary of Health and Human Services shall review and if necessary revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, established pursuant to section 503(a) of Public Law 100–71 (5 U.S.C. 7301 note), to expand the list of substances authorized for testing to include any such drugs which may not have been previously included, and which the Secretary believes should be included.

(b)

Publication of notice

Upon completion of the revision required under subsection (a), the Secretary shall publish a final notice in the Federal Register of such revision.

5.

Inclusion of newly established drugs in department of transportation drug tests

Not later than 60 days after the final notice required under section 4(b) is published, the Secretary of Transportation shall issue such regulations as are necessary to update any regulations containing procedures for transportation employee workplace drug and alcohol testing programs to include testing for newly identified substances in drug-testing panels, consistent with the Mandatory Guidelines for Federal Workplace Drug Testing Programs as revised by the Secretary of Health and Human Services under section 4.